$1.89
0.15.59%
At close: -
$1.84
-0.05-2.65%
After Hours: 5:54 PM EDT
Comments
Loading...
Acumen Pharmaceuticals (ABOS) Forecast
NewsEarningsAcumen Pharmaceuticals (ABOS) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAcumen Pharmaceuticals (NASDAQ:ABOS) Stock Quotes, Forecast and News Summary
Acumen Pharmaceuticals Stock (NASDAQ: ABOS) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Acumen Pharmaceuticals (ABOS) stock?
You can purchase shares of Acumen Pharmaceuticals (NASDAQ:ABOS) through any online brokerage.
Who are Acumen Pharmaceuticals (ABOS) competitors?
Other companies in Acumen Pharmaceuticals’s space includes: Cabaletta Bio (NASDAQ:CABA), Adverum Biotechnologies (NASDAQ:ADVM), Atossa Therapeutics (NASDAQ:ATOS), Abpro Hldgs (NASDAQ:ABP) and Lineage Cell Therapeutics (AMEX:LCTX).
What is the forecast, or price target, for Acumen Pharmaceuticals (ABOS) stock?
Acumen Pharmaceuticals has a consensus price target of $12.25.
What is the current price for Acumen Pharmaceuticals (ABOS)?
The stock price for Acumen Pharmaceuticals (NASDAQ: ABOS) is $1.84 last updated December 26, 2024 at 5:54 PM EST.
Does Acumen Pharmaceuticals (ABOS) pay a dividend?
There are no upcoming dividends for Acumen Pharmaceuticals.
When is Acumen Pharmaceuticals (NASDAQ:ABOS) reporting earnings?
Acumen Pharmaceuticals’s Q4 earnings are confirmed for Tuesday, March 25, 2025.
Is Acumen Pharmaceuticals (ABOS) going to split?
There is no upcoming split for Acumen Pharmaceuticals.
What sector and industry does Acumen Pharmaceuticals (ABOS) operate in?
Acumen Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.